Molecular Templates Incorporated (NASDAQ:MTEM) had an increase of 25.47% in short interest. MTEM’s SI was 251,200 shares in January as released by FINRA. Its up 25.47% from 200,200 shares previously. With 70,700 avg volume, 4 days are for Molecular Templates Incorporated (NASDAQ:MTEM)’s short sellers to cover MTEM’s short positions. The stock increased 7.20% or $0.87 during the last trading session, reaching $12.96. About 197,368 shares traded or 51.37% up from the average. Molecular Templates, Inc. (NASDAQ:MTEM) has 0.00% since January 16, 2017 and is . It has underperformed by 16.70% the S&P500.
Trellus Management Company Llc decreased Canadian Solar Inc (CSIQ) stake by 56.91% reported in 2017Q3 SEC filing. Trellus Management Company Llc sold 21,400 shares as Canadian Solar Inc (CSIQ)’s stock declined 8.07%. The Trellus Management Company Llc holds 16,200 shares with $273,000 value, down from 37,600 last quarter. Canadian Solar Inc now has $959.95M valuation. The stock decreased 4.34% or $0.75 during the last trading session, reaching $16.55. About 1.83M shares traded or 63.82% up from the average. Canadian Solar Inc. (NASDAQ:CSIQ) has declined 25.32% since January 16, 2017 and is downtrending. It has underperformed by 42.02% the S&P500.
Among 17 analysts covering Canadian Solar Inc. (NASDAQ:CSIQ), 9 have Buy rating, 2 Sell and 6 Hold. Therefore 53% are positive. Canadian Solar Inc. had 40 analyst reports since August 19, 2015 according to SRatingsIntel. The company was downgraded on Wednesday, August 24 by Barclays Capital. The stock has “Hold” rating by Standpoint Research on Wednesday, November 25. FBR Capital maintained the stock with “Market Perform” rating in Wednesday, August 16 report. The company was maintained on Monday, August 14 by Oppenheimer. Cowen & Co initiated Canadian Solar Inc. (NASDAQ:CSIQ) rating on Tuesday, August 25. Cowen & Co has “Outperform” rating and $28.50 target. The rating was maintained by Cowen & Co with “Hold” on Friday, October 20. Cowen & Co downgraded Canadian Solar Inc. (NASDAQ:CSIQ) rating on Friday, August 19. Cowen & Co has “Market Perform” rating and $13 target. The rating was initiated by Stifel Nicolaus with “Buy” on Thursday, September 24. As per Friday, November 10, the company rating was upgraded by Roth Capital. Canaccord Genuity maintained the stock with “Buy” rating in Thursday, December 17 report.
Analysts await Canadian Solar Inc. (NASDAQ:CSIQ) to report earnings on March, 20. They expect $1.06 EPS, up 341.67% or $0.82 from last year’s $0.24 per share. CSIQ’s profit will be $61.48M for 3.90 P/E if the $1.06 EPS becomes a reality. After $0.22 actual EPS reported by Canadian Solar Inc. for the previous quarter, Wall Street now forecasts 381.82% EPS growth.
Molecular Templates, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of immunotoxins called engineered toxin bodies for the treatment of cancer and other serious diseases. The company has market cap of $348.56 million. It develops MT-3724, a lead drug candidate that is in a Phase 1 clinical trial in heavily pre-treated non-Hodgkin's lymphoma patients; MT-4019, a preclinical drug candidate targeting CD38; and evofosfamide, an investigational hypoxia-activated prodrug of a bis-alkylating agent that is preferentially activated under severe hypoxic tumor conditions, a feature of many solid tumors. It currently has negative earnings.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.